Keywords
abuse
risk.
Abstract
Chronic pain is one of the most frequent medical problems and its relief should be a priority therapeutic goal; Opioid analgesics constitute the cornerstone, however, in chronic pain and the addictive potential of these drugs, as well as their misuse and the worrying increase in overdose deaths in some countries such as the US, have forced health authorities to implement coordinated strategies to promote safe and responsible prescribing, to mitigate risks in the use of opioids.References
1. Verástegui E, Plancarte R, Domínguez J, Burgos R, Arrieta O, Campillo C, et al. Recomendaciones para la prescripción segura de opioides en el manejo del dolor crónico no oncológico. Gac Med Mex. 2018;154(4):532-3.
2. Tutt B. Administración del uso de opioides en pacientes con cáncer. OncoLog. 2018;63(3).
3. González Gragera MB. Santamaría Semís J, Rodríguez Quintana R, Iglesias González M, Julià i Torras J. Adicción frente a seudoadicción. Med Paliat. 2015;22(S1):20-6.
4. Paice J. Risk Assessment and monitoring of patients with cancer receiving opioid therapy . Oncologist. 2019;24(10):1294-8.
5. O'Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, Mcquay HJ, et al. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21(1):3-19.
6. Opioids Aware [Internet]. Faculty of Pain Medicine of the Royal College of Anaesthetists; 2022. Disponible en: https://fpm.ac.uk/opioids-aware
7. Sobredosis de opioides [Internet]. Organizacion Mundial de la Salud; 2020. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/opioid-overdose
8. World Drug Report 2019 [Internet]. United Nations; 2022. Disponible en: https://wdr.unodc.org/wdr2019/
9. Opioid Overdose Crisis [Internet]. National Institutes of Health; 2021. Disponible en: https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis
10. Glosario y términos de alcohol y drogas [Internet]. World Health Organization; 1994. Disponible en: https://www.who.int/substance_abuse/terminology/lexicon_alcohol_drugs_spanish.pdf
11. Carmona-Bayonas A, Jiménez-Fonseca P, Castañón E, Ramchandani-Vaswani A, Sánchez-Bayona R, Custodio A, et al. Chronic opioid therapy in long term cancer survivors. Clin Transl Oncol. 2017;19(2):236-50. DOI: 10.1007/s12094-016-1529-6.
12. Guía de consulta de los Criterios Diagnósticos del DSM-5 [Internet]. American Psychiatric Association; 2014. Disponible en: https://www.eafit.edu.co/ninos/reddelaspreguntas/Documents/dsm-v-guia-consulta-manual-diagnostico-estadistico-trastornos-mentales.pdf
13. George B, Minello C, Allano G, Maindet C, Burnod A, Lemaire A. Opioids in cancer-related pain: current situation and outlook. Support Care Cancer. 2019;27(8):3105-18.
14. Boscarino J, Rukstalis M, Hoffman S, Han JJ, Erlich PM, Gerhard GS, et sl. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105(10):1776-82.
15. Fabbro E. Assessment and Management of Chemical Coping in Patients With Cancer. J Clin Oncol. 2014;32(16):1734-8.
16. Salsitz E. Chronic Pain, Chronic Opioid Addiction: a Complex Nexus. J Med Toxicol. 2016;12(1):54-7.
17. Pineda-Ortiz J, Torrecilla-Sesma M. Mecanismos neurobiológicos de la adicción a drogas. Trastornos Adictivos. 1999;1(1):13-21.
18. Acuña JP. Riesgo de adicción a analgésicos opioides en el tratamiento de dolor crónico no oncológico. Revista Médica Clínica Las Condes. 2019;30(6):466-79.
19. Nestler E. Under siege: The brain on opiates. Neuron. 1996;16(5):897-900.
20. Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22(2):173-81.
21. Kosten T, George T. The Neurobiology of Opioid Dependence: Implications for Treatment. Sci Pract Perspect. 2002;1(1):13-20.
22. Sehgal N, Manchikanti L, Smith HS. Prescription Opioid Abuse in Chronic Pain: A Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse. Pain Physician. 2012;15(3 Suppl):ES67-92.
23. Brown RL, Leonard T, Saunders LA, Papasouliotis O. The prevalence and detection of substance use disorder among inpatients ages 18 to 49: an opportunity for prevention. Preventive Medicine. 1998;27(1):101-10.
24. Carvajal Valcárcel A, Martínez García M, Centeno Cortés C. Versión española del Edmonton Symptom Assessment Sytem (ESAS): un instrumento de referencia para la valoración sintomática del paciente con cáncer avanzado. Med Paliat. 2013;20(4):143-9.
25. Pain Management Best Practices [Internet]. Inter-Agency Task Force, U.S. Department of Health and Human Services; 2019. Disponible en: https://www.hhs.gov/sites/default/files/pmtf-final-report-2019-05-23.pdf
26. Becker WC, Edelman EJ, Starrels JL, Azari S, Roy P, Young SR, et al. Consensus-Based Treatment Approaches for Managing Concerning Behaviors in Patients on Long-term Opioid Therapy for Chronic Pain: Case-Based Applications. Mayo Clin Proc Innov Qual Outcomes. 2018;2(2):91-8.
27. Parisi A, Pensieri MV, Cortellini A, D'Orazio C, Ficorella C, Verna L, et al. Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series. J Addict Dis. 2020;38(2):229-34.
28. Ramírez Arias E. Diagnóstico y tratamiento de la dependencia a los opioides. Rev Med Costa Rica y Centroam. 2013;LXX(608):593-7.